The Journal of Antibiotics · 1987 · 27 citations · 7 references
Life SciencesImmunologyPharmacologyImmunopharmacologyImmunoregulationTransplant ImmunologyAllograft RejectionAntibody-mediated RejectionImmunosuppressionTransplant ImmunopharmacologyTransplant PharmacologyTransplant RejectionAllogeneic Skin GraftsImmune Response To AllograftImmunologic Response To AllograftImmunosuppressive CompoundsImmunosuppressive Function
The immunosuppressive activity of spergualin analogues, 15-deoxyspergualin and N-30, is presented. These compounds suppressed antibody formation and establishment of delayed-type hypersensitivity to sheep red blood cells (SRBC) in mice. Among spergualin, 15-deoxyspergualin, and N-30, 15-deoxyspergualin was most effective in suppressing immune responses. It suppressed antibody formation against SRBC by spleen cell cultures in a dose-dependent fashion without reducing cell viability. The spergualins also suppressed the mixed lymphocyte culture reaction. Peritoneal exudate cells taken from mice given immunosuppressive doses of 15-deoxyspergualin were not reduced in their functions measured: Release of lysosomal enzymes and production of superoxide anions. 15-Deoxyspergualin and N-30 were markedly effective in prolonging skin graft in rats.
7
Effect of bestatin on mouse immune system and experimental murine tumors.
Masaaki Ishizuka, Toru Masuda, NOBUO KANBAYASHI et al. · The Journal of Antibiotics · 1980 · 131 citations · Full text
Medicine, Immunology, Oncology +14
Suppression of tissue graft rejection by spergualin.
HAMAO UMEZAWA, Masaaki Ishizuka, TOMIO TAKEUCHI et al. · The Journal of Antibiotics · 1985 · 70 citations · Full text
Life Sciences, Immunology, Surgery +12
EFFECT OF DIKETOCORIOLIN B ON ANTIBODY FORMATION
Masaaki Ishizuka, HIRONOBU IINUMA, TOMIO TAKEUCHI et al. · The Journal of Antibiotics · 1972 · 39 citations · Full text